Screening of CPT1A-Targeting Lipid Metabolism Modulators Using Mitochondrial Membrane Chromatography

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Carnitine palmitoyltransferase 1A (CPT1A) is the rate-limiting enzyme in fatty acid beta-oxidation, making it a key target for metabolic regulation.
• Identifying specific modulators of CPT1A is crucial for developing therapeutic strategies for metabolic disorders.

Purpose of the Study:

• To develop and validate a novel screening system for identifying compounds that interact with CPT1A.
• To discover new agonists or enhancers of CPT1A activity from complex natural product extracts.

Main Methods:

• Development of a CPT1A-overexpressed mitochondrial membrane chromatography (MMC) system.
• Isolation and immobilization of mitochondrial membranes onto chromatography supports.
• Analysis of eluted compounds using Liquid Chromatography-Mass Spectrometry (LC/MS).

Main Results:

• The MMC-LC/MS approach successfully screened traditional Chinese medicine extracts.
• Five compounds, including baicalin, baicalein, wogonoside, wogonin, and resveratrol, were identified as CPT1A activity enhancers.
• Resveratrol was identified as a novel agonist for CPT1A.

Conclusions:

• The developed MMC system is a reliable and efficient method for screening CPT1A modulators from complex mixtures.
• The identified compounds, particularly resveratrol, show potential for modulating lipid metabolism through CPT1A activation.